{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T13:18:50Z","timestamp":1773235130018,"version":"3.50.1"},"reference-count":27,"publisher":"BMJ","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Clin Pathol"],"accepted":{"date-parts":[[2011,9,6]]},"published-print":{"date-parts":[[2012,2]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>\n                      In order for\n                      <jats:italic>Chlamydia pneumoniae<\/jats:italic>\n                      to play a causative role in chronic human disease, it would need to persist within infected tissue for extended periods of time. Current theory suggests that\n                      <jats:italic>C pneumoniae<\/jats:italic>\n                      may persist at the site of infection via an alternative replicative form, known as an aberrant body.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A panel of\n                      <jats:italic>C pneumoniae<\/jats:italic>\n                      -specific antibodies upregulated by the aberrant body was used to probe tissue specimens from the coronary atheroma from 13 explanted hearts to identify patterns of reactivity in these tissues, as well as to determine the presence and prevalence of\n                      <jats:italic>C pneumoniae<\/jats:italic>\n                      aberrant bodies.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Six of 13 patients had an ischaemic cardiomyopathy secondary to coronary atherosclerosis, while another six patients had an idiopathic, dilated cardiomyopathy. One additional patient, a young (24\u2005years) woman with cardiomyopathy, had no history of atherosclerotic disease. Eleven patients were positive by immunohistochemistry with at least one antibody. Coronary arteries of the two other patients were negative by immunohistochemistry with all antibodies. One of these patients was the 24-year-old woman with grade I disease and no risk factors for coronary artery disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      The protein antigens of persistent\n                      <jats:italic>C pneumoniae<\/jats:italic>\n                      infection found in the atheromatous lesions from patients in this study could potentially be used as markers to detect such infections and some may be virulence factors or immunogens specific to\n                      <jats:italic>C pneumoniae<\/jats:italic>\n                      , thus serving as target molecules for diagnostic use or therapeutic intervention.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jclinpath-2011-200270","type":"journal-article","created":{"date-parts":[[2011,11,2]],"date-time":"2011-11-02T20:59:57Z","timestamp":1320267597000},"page":"171-177","source":"Crossref","is-referenced-by-count":9,"title":["Antigens of persistent\n                    <i>Chlamydia pneumoniae<\/i>\n                    within coronary atheroma from patients undergoing heart transplantation"],"prefix":"10.1136","volume":"65","author":[{"given":"Nicole","family":"Borel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Pospischil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D","family":"Dowling","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Dumrese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte A","family":"Gaydos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sebastian","family":"Bunk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corinna","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio A","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James T","family":"Summersgill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2011,11,2]]},"reference":[{"key":"2025112109410781000_65.2.171.1","doi-asserted-by":"publisher","DOI":"10.1093\/clind\/15.5.757"},{"key":"2025112109410781000_65.2.171.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198607173150305"},{"key":"2025112109410781000_65.2.171.3","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/14.1.178"},{"key":"2025112109410781000_65.2.171.4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1128\/CMR.8.4.451","article-title":"Chlamydia pneumoniae (TWAR)","volume":"8","author":"Kuo","year":"1995","journal-title":"Clin Microbiol Rev"},{"key":"2025112109410781000_65.2.171.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.288.21.2724"},{"key":"2025112109410781000_65.2.171.6","doi-asserted-by":"crossref","unstructured":"Wyrick PB . Chlamydia trachomatis persistence in vitro: an overview. J Infect Dis 2010;(201 Suppl 2):S88\u201395.","DOI":"10.1086\/652394"},{"key":"2025112109410781000_65.2.171.7","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.4.1843-1855.2004"},{"key":"2025112109410781000_65.2.171.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.vetmic.2008.09.035"},{"key":"2025112109410781000_65.2.171.9","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2334-6-152"},{"key":"2025112109410781000_65.2.171.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2007.09.026"},{"key":"2025112109410781000_65.2.171.11","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2180-8-190"},{"key":"2025112109410781000_65.2.171.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2006.11.006"},{"key":"2025112109410781000_65.2.171.13","doi-asserted-by":"publisher","DOI":"10.1099\/00207713-49-2-415"},{"key":"2025112109410781000_65.2.171.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcp.2005.09.003"},{"key":"2025112109410781000_65.2.171.15","unstructured":"Ramachandran P Agreda P Gaydos CA . Rapid Identification of any Chlamydia sp. Through Multi Probe Real-time Polymerase Chain Reaction (PCR) and High Resolution Melt Curve Analysis (HRMA) Using 16S rRNA as the Target. Abst #C-141; 17\u201321 May 2009, Philadelphia, PA: American Society for Microbiology."},{"key":"2025112109410781000_65.2.171.16","doi-asserted-by":"crossref","first-page":"5490","DOI":"10.4049\/jimmunol.180.8.5490","article-title":"Immunoproteomic identification and serological response to novel Chlamydia pneumoniae antigens that are associated with persistent C. pneumoniae infections","volume":"80","author":"Bunk","year":"2008","journal-title":"J Immunol"},{"key":"2025112109410781000_65.2.171.17","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1128\/CVI.00209-09","article-title":"Chlamydia pneumoniae-induced memory CD4+ T-cell activation in human peripheral blood correlates with distinct antibody response patterns","volume":"217","author":"Bunk","year":"2010","journal-title":"Clin Vaccine Immunol"},{"key":"2025112109410781000_65.2.171.18","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1136\/jcp.53.12.911","article-title":"Chlamydia pneumoniae antigens, rather than viable bacteria, persist in atherosclerotic lesions","volume":"52","author":"Meijer","year":"2000","journal-title":"J Clin Pathol"},{"key":"2025112109410781000_65.2.171.19","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.53.12.904"},{"key":"2025112109410781000_65.2.171.20","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.70.6.2976-2981.2002"},{"key":"2025112109410781000_65.2.171.21","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.02104-05"},{"key":"2025112109410781000_65.2.171.22","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200804023"},{"key":"2025112109410781000_65.2.171.23","doi-asserted-by":"publisher","DOI":"10.1046\/j.1462-5822.2003.00278.x"},{"key":"2025112109410781000_65.2.171.24","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.72.12.7164-7171.2004"},{"key":"2025112109410781000_65.2.171.25","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M610754200"},{"key":"2025112109410781000_65.2.171.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2007.06.039"},{"key":"2025112109410781000_65.2.171.27","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.tim.2007.04.005","article-title":"Type III secretion system \u00e0 la Chlamydia","volume":"6","author":"Peters","year":"2007","journal-title":"Trends Microbiol"}],"container-title":["Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jclinpath-2011-200270","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T17:41:12Z","timestamp":1763746872000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcp.bmj.com\/lookup\/doi\/10.1136\/jclinpath-2011-200270"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11,2]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,1,19]]},"published-print":{"date-parts":[[2012,2]]}},"alternative-id":["10.1136\/jclinpath-2011-200270"],"URL":"https:\/\/doi.org\/10.1136\/jclinpath-2011-200270","relation":{},"ISSN":["0021-9746","1472-4146"],"issn-type":[{"value":"0021-9746","type":"print"},{"value":"1472-4146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,11,2]]}}}